([ Ссылка ]) Meningiomas can be hard to diagnose because they often grow slowly and it can take years for the onset of symptoms to occur. In this episode, Stephen T. Magill, MD, PhD, talks about how advances in meningioma classification have improved recurrence predictions and potential therapeutic targets. Dr. Magill, an assistant professor of Neurological Surgery at Northwestern Medicine, specializes in surgical neuro-oncology, and his research focuses on meningioma biology and patient outcomes.

свернуть